Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Challenges and opportunities toward enabling phenotypic screening of complex and 3D cell models.

Future medicinal chemistry - 1 Jan 2015

Horman Shane R, Hogan Christopher, Delos Reyes Karlo, Lo Frederick, Antczak Christophe

Abstract excerpt

Increasingly, organotypic cellular platforms are being recognized as useful tools in drug discovery. This review offers an industry-centric perspective on the benefits of emerging complex cell models over conventional 2D systems, as well as the challenges and opportunities for incorporating these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cells
Share to Drug Design
Share to Drug Discovery

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Screening Assays

Share to Induced Pluripotent Stem Cells

Share to Models, Biological

Share to Phenotype

Source

Identifiers

PMID: 25875876
DOI: 10.4155/fmc.14.163

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25875876-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Challenges and opportunities toward enabling phenotypic screening of complex and 3D cell models.PMID 25875876Read ↗

Development of an automated 3D high content cell screening platform for organoid phenotyping.Semantic proximity Read ↗

Drug Discovery Goes Three-Dimensional: Goodbye to Flat High-Throughput Screening?Semantic proximity Read ↗

Organoids in image-based phenotypic chemical screensSemantic proximity Read ↗

Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug RepositioningSemantic proximity Read ↗

Functional Drug Screening in the Era of Precision MedicineSemantic proximity Read ↗

3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer DrugsSemantic proximity Read ↗

Developing Defined and Scalable 3D Culture Systems for Culturing Human Pluripotent Stem Cells at High DensitiesSemantic proximity Read ↗

Whole-Process 3D ECM-Encapsulated Organoid-Based Automated High-Throughput Screening Platform Accelerates Drug Discovery for Rare DiseasesSemantic proximity Read ↗

High-content interrogation of human induced pluripotent stem cell-derived cortical organoid platformsSemantic proximity Read ↗

High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.Semantic proximity Read ↗

A high-throughput 3D culture microfluidic platform for multi-parameter phenotypic and omics profiling of patient-derived organoidsSemantic proximity Read ↗

Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screeningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.